Introduction
Cancer is the top cause of death worldwide, but there are big differences between regions in both the overall rate of occurrence and the rate of occurrence in certain organs. A global age-standardized cancer rate list can help find the countries and regions where a certain type of tumor is most common. These differences usually show that exposure to different environmental factors causes harm. Descriptive epidemiology tells us about common cancer diseases and helps us decide how to use resources, plan health services, and keep people from getting sick.
What Are the Reasons Behind the Increasing Global Cancer Rates?
Cancer ranks as the second most prevalent cause of mortality globally, with cancer being responsible for ten million deaths in the year 2020.
-
Low- And Middle-Income Countries: Of the total number of cancer-related fatalities globally, which amounted to approximately ten million, 70 percent occurred in low- and middle-income countries. The discrepancy is particularly pronounced in the context of cervical cancer, where 90 percent of cases that occur and deaths from this avoidable disease transpire in low- and middle-income countries.
-
Insufficient Resources: Low and middle-income countries (LMICs) have insufficient resources to effectively address the significant problems that cancer poses to their national health systems. Consequently, residents face barriers in obtaining cancer-preventing vaccination and screening, experience delayed diagnosis, lack access to therapy and pain management, and do not receive sufficient support to address their psycho-social and resource requirements.
-
Failure to Use Established Treatments: Despite the significant advancements in knowledge of cancer, it remains a prominent cause of death, mostly due to the failure to implement established therapies. An all-encompassing approach emphasizing prevention, early diagnosis, treatment, and pain management is crucial for saving lives and reducing unnecessary agony. This approach will also accelerate cancer control in the next few years.
What Are the Prevention and Treatment of Cancer?
The provided overview of cancer worldwide is a limited analysis of the extensive data available on the global spread of cancer. The prevalence of cancer worldwide varies depending on the population. The degree of variety is evident when comparing subcontinental regions, and this variation is equally noticeable at both the national and local district levels. The variation in cancer incidence can be primarily attributed to and indicates the impact of specific risk factors. Several well-established risk variables function as causal factors for diseases, and the corresponding biological mechanisms are becoming increasingly elucidated.
-
Understanding the underlying factors that contribute to cancer development offers the potential to prevent or identify it at an early stage. The shift from documenting disease to using it as a foundation for taking action can also be applied to therapy. Therefore, the incidence, mortality, and other data provide valuable information on the prognosis and effectiveness of treatment for certain forms of cancer.
-
The prevalence of cancer varies throughout time, and specific evaluations typically pertain to a certain timeframe. Regardless of any changes in distribution, the burden of cancer persists. This load entails significant disturbance, caused by intense misery, to the lives of hundreds of millions of people worldwide. As this volume will demonstrate, the burden can be gradually reduced through suitable intervention.
Which Are the Regional Disparities in the Prevalence of Cancer?
Cancer incidence in twelve broad "regions." Even across vast geographic regions, the locations and ranks of the most prevalent tumors varied significantly. Furthermore, it is critical to note that there are some striking parallels.
-
There is some evidence to support the validity of distinguishing cancer incidence in more and less developed nations based on similar cancer incidence trends. The most prevalent cancers in these areas are colorectal, lung, breast, and prostate. The sole exception to this pattern is the significant increase in melanoma incidence, which is a frequent malignancy in Australia and New Zealand. Stomach cancer is more common in Central and Southern Europe; therefore, these locations deviate slightly from this pattern. Except for Oceania, all regions rank fifth or sixth regarding bladder cancer rates.
-
East Asia consists of states and groups classified as "more developed" or "less developed." It covers parts of China and Japan. The distribution of lung, colorectal, and breast cancers is similar to that of more developed countries. However, it varies in terms of the incidence of liver, esophageal, and stomach cancers, all of which are serious issues. No apparent subset of malignancies forms a pattern in underdeveloped countries. Rather, some patterns are specific to vast geographical areas.
-
Breast cancer affects communities in both developed and poor countries. Cervical cancer is a major issue in many poor countries, particularly South America, Sub-Saharan Africa, and South Central Asia. On the other hand, some malignancies are more prevalent in particular parts of the world than others. Oral cancer is prominent in South Central Asia, and liver cancer is particularly prevalent in Sub-Saharan Africa and other Asian countries. In Western Asia and Northern Africa, bladder cancer is a severe problem.
How to Reduce the Burden?
-
Approximately 30 to 50 percent of cancer cases are avoided by avoiding from risk factors and using established preventative measures.
-
Early detection of cancer and effective treatment and care of patients can help lessen the burden of cancer. Many cancers can be effectively cured if detected early and managed appropriately.
Conclusion
Cancer typically affects the elderly. If nothing else changes, demographic change (population growth and aging) will increase cancer worldwide. Cancer incidence is predicted by GLOBOCAN 2002. If age-specific incidence rates remain constant, population growth and aging will increase the world population. Women have a similar cancer incidence in all areas except the case of skin cancer which will seen more often in female patients. This highlights the need to study cancer risk factors, develop effective preventative methods, and improve treatment options.
Populations in developed and developing nations differ substantially. Less developed nations have fewer seniors. As cancer incidence grows with age, less developed countries have a larger population base and more room for aging. Global cancer rates will undoubtedly climb in developing nations. The survey demonstrates that industrialized and developing nations have different cancer causes and outcomes. Underdeveloped countries have one in four infectious cancer cases compared to other developed countries. These differences suggest industrialized and poor countries should invest in cancer research on etiology, prevention, therapy, and health policy to reduce cancer internationally.
